CVS HEALTH REPORTS STRONG SECOND QUARTER RESULTS, RAISES 2022 FULL-YEAR EPS AND CASH FLOW FROM OPERATIONS GUIDANCE
Go back to CVS HEALTH REPORTS STRONG SECOND QUARTER RESULTS, RAISES 2022 FULL-YEAR EPS AND CASH FLOW FROM OPERATIONS GUIDANCE| CVS Caremark Corp. (NYSE: CVS) | Delayed: 93.95 -0.8 (0.84%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $94.75 | 52 Week High | $106.67 | |||
| Open | $95.26 | 52 Week Low | $69.30 | |||
| Day High | $95.26 | P/E | 25.05 | |||
| Day Low | $93.72 | EPS | $3.75 | |||
| Volume | 3,432,134 | |||||



